Genetic aberration in primary hepatocellular carcinoma: Correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23

Cell Research

Volumn 10, Issue 4, 2000, Pages 311-323

  Wang, Gang ^a,b   Huang, Chang Hui ^b   Zhao, Yan ^b   Cai, Ling ^b   Wang, Ying ^b   Xiu, Shi Jin ^b   Jiang, Zheng Wen ^b   Yang, Shuang ^b   Zhao, Xin Tai ^a   Huang, Wei ^b   Gu, Jian Ren ^a  

^a SHANGHAI CANCER INSTITUTE   (China)

^b CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

Hepatocellular carcinoma; Loss of heterozygosity (LOH); Microsatellite marker; p53 gene mutation

Indexed keywords

CADHERIN; MICROSATELLITE DNA;

ARTICLE; CHINA; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 9; GENE DELETION; GENETICS; HETEROZYGOSITY LOSS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MUTATION; TUMOR SUPPRESSOR GENE;

CADHERINS; CARCINOMA, HEPATOCELLULAR; CHINA; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 9; GENE DELETION; GENES, P16; GENES, P53; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MUTATION;

EID: 0034569081     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cr.7290058     Document Type: Article

References (34)

1. Akriviadis EA, Llovet JM, Efremidis SC, et al. Hepatocellular carcinoma. Br J Surg. 1998; 85: 1319-31.
2. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353:1253-7.
3. Simonetti RG, Camma C, Fiorello F, Politi F, D'amico G, Pagliaro L. Hepatocellular carcinoma, a worldwide problem and the major risk factors. Dig Dis Sci 1991; 36:962-72.
4. Chen GJ, Wang LY, Lu SN, et al. Elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Hepatology 1996; 24:38-42.
5. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal Structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic matations. Science 1994; 265:346-55.
6. Montesano R, Hainaut P, Wild CP. Hepatocellular carcinoma, from gene to public health. J Natl Cancer Inst. 1997; 89:1844-51.
7. Rashid A, Wang JS, Qian GS, Lu BX, Hamilton SR, Groopman JD. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations. Br J Cancer 1999; 80:59-66.
8. Khakoo SI, Grellier LF, Soni PN, Bhattacharya S, Dusheiko GM. Etiology, screening, and treatment of hepatocellular carcinoma. Med Clin North Am. 1996; 80:1121-45.
9. Jia L, Wang XW, Harris CC. Hepatitis B virus X protein inhibits nucleotide excision repair. Int J Cancer 1999; 80:875-9.
10. Fujimoto Y, Hampton LL, Wirth PJ, et al. Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res. 1994; 54:281-5.
11. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res. 1992; 52:6358-64.
12. Li DZ, Cao YP, He LP, Wang NJ, Gu JR. Aberrations of p53 in human hepatocellular carcinoma. Carcinogenesis 1993; 14:169-73.
13. Shi CY, Phang TW, Lin Y, et al. Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethinic Chinese in Singapore. Br J Cancer 1995; 72:146-9.
14. Yamada T, De Souza AT, Finkelstein S, Jirtle RL. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci USA 1997; 94:10351-5.
15. De La Coste A, Romagnolo B, Billuart P, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998; 95:8847-51.
16. Huang H, Fujii H, Sankila A, et al. β-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am J Pathol 1999; 155:1795-801.
17. Marchio A, Meddeb M, Pineau P, et al. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer 1997; 18:59-65.
18. Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997; 14:2927-33.
19. Piao Z, Park C, Park JH, Kim H. Allelotyping analysis of hepatocellular carcinoma, Int J Cancer 1998; 75:29-33.
20. Wong N, Lai P, Lee SW, et al. Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: relationship to disease stage, tumor size, and cirrhosis. Am J Pathol 1999; 154:37-43.
21. Maniatis T, Fritsch J, Sambrook J. Molecular Cloning (a laboratory manual). Cold Spring Harbor Laboratory 1989; 9.37-9.57.
22. Cunningham JM, Shan A, Wick MJ, et al. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res. 1996; 56:4475-82.
23. Hussussian CJ, Struewing JP, Goldstein AM, et al. Germline p16 mutations in familial melanoma. Nat Genet 1994; 8:15-21.
24. Berx G, Cleton-Jansen AM, Nollet F, et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14:6107-15.
25. Kim JR, Kim SY, Kim MJ, Kim JH. Alterations of CDKN2 (MTS1/p16INK4A) gene in paraffin-embedded tumor tissues of human stomach, lung, cervix and liver cancers. Exp Mol Med 1998; 30:109-14.
26. Liew CT, Li HM, Lo KW, et al. High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene 1999; 18:789-95.
27. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG. In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA 1999; 96:12754-9.
28. Biden K, Young J, Buttenshaw R, et al. Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population. Hepatology 1997; 25:593-7.
29. Tsuda H, Zhang WD, Shimosato Y, et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87:6791-4.
30. Handschuh G, Candidus S, Luber B, et al. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility. Oncogene 1999; 18:4301-12.
31. Kozyraki R, Scoazec JY, Flejou JF, et al. Expression of cadherins and a-catenin in primary epithelial tumors of the liver. Gastroenterology 1996; 110:1137-49.
32. Osada T, Sakamoto M, Ino Y, et al. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 1996; 24:1460-7.
33. Miyoshi Y, Iwao K, Nagasawa Y, et al. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 1998; 58:2524-7.
34. Kanai Y, Ushijima S, Hui AM, et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int J Cancer 1997; 71:355-9.